The use of chemotherapy in the treatment of selected types of early breast cancer has been
endorsed as a measure of high-quality care by numerous professional organizations and …

Purpose Underuse of adjuvant therapy is a potentially important and remediable
explanation for the inferior survival of minority women with breast cancer. We sought to …

Importance Declining treatment negatively affects health outcomes among patients with
cancer. Limited research has investigated national trends of and factors associated with …

Background Surgical resection is the cornerstone of therapy in patients with nonmetastatic
breast cancer. Previous studies have reported underuse of adjuvant therapy among African …

BACKGROUND: Consistent with findings from clinical trials, a recent population‐based
study indicated that adjuvant chemotherapy for lymph node‐positive, operable breast cancer …

PURPOSE: We sought to examine tumor subtype, stage at diagnosis, time to surgery (TTS),
and overall survival (OS) among Hispanic patients of different races and among Hispanic …

Purpose There are a paucity of data and a pressing need to evaluate response to
neoadjuvant chemotherapy (NACT) and determine long-term outcomes in young Black …

Objectives Clinical guidelines recommend that when breast-conserving surgery is provided
as primary therapy for early-stage breast cancer, radiation therapy should follow. We do not …

Importance Racial disparities in time to surgery (TTS) after a breast cancer diagnosis and
whether these differences account for disparities in overall survival have been understudied …

BACKGROUND: Racial disparities in breast cancer outcomes are attributed to differences in
baseline tumour characteristics and biology, stage, age, ethnic background and …